Russell Investments Group, Ltd. Neurocrine Biosciences Inc Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 210,777 shares of NBIX stock, worth $31.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
210,777
Previous 288,761 27.01%
Holding current value
$31.1 Million
Previous $39.8 Million 38.96%
% of portfolio
0.04%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$114.58 - $153.15 $8.94 Million - $11.9 Million
-77,984 Reduced 27.01%
210,777 $24.3 Million
Q2 2024

Aug 08, 2024
SELL
$130.86 - $143.19 $7.92 Million - $8.67 Million
-60,556 Reduced 17.34%
288,761 $39.8 Million
Q1 2024

May 08, 2024
SELL
$130.4 - $143.74 $7.3 Million - $8.04 Million
-55,962 Reduced 13.81%
349,317 $48.2 Million
Q4 2023

Feb 05, 2024
SELL
$106.07 - $132.76 $908,383 - $1.14 Million
-8,564 Reduced 2.07%
405,279 $53.4 Million
Q3 2023

Nov 13, 2023
BUY
$94.02 - $117.1 $1.27 Million - $1.58 Million
13,479 Added 3.37%
413,843 $46.6 Million
Q2 2023

Aug 10, 2023
BUY
$89.53 - $104.87 $5.16 Million - $6.04 Million
57,582 Added 16.8%
400,364 $37.8 Million
Q1 2023

May 09, 2023
BUY
$94.11 - $123.02 $17.5 Million - $22.9 Million
186,397 Added 119.19%
342,782 $34.7 Million
Q4 2022

Feb 08, 2023
BUY
$106.72 - $127.06 $3.63 Million - $4.33 Million
34,048 Added 27.83%
156,385 $18.7 Million
Q3 2022

Nov 04, 2022
SELL
$92.03 - $107.81 $2.76 Million - $3.23 Million
-29,963 Reduced 19.67%
122,337 $13 Million
Q2 2022

Jul 29, 2022
BUY
$75.79 - $100.07 $895,383 - $1.18 Million
11,814 Added 8.41%
152,300 $14.8 Million
Q1 2022

May 05, 2022
BUY
$72.45 - $94.81 $6.49 Million - $8.5 Million
89,615 Added 176.16%
140,486 $13.2 Million
Q4 2021

Jan 21, 2022
BUY
$79.65 - $106.22 $1.33 Million - $1.77 Million
16,648 Added 48.65%
50,871 $4.33 Million
Q3 2021

Nov 08, 2021
BUY
$86.18 - $99.03 $1.07 Million - $1.22 Million
12,369 Added 56.6%
34,223 $3.28 Million
Q2 2021

Aug 04, 2021
BUY
$89.43 - $102.27 $425,060 - $486,089
4,753 Added 27.79%
21,854 $2.13 Million
Q1 2021

May 10, 2021
BUY
$87.57 - $119.4 $268,839 - $366,558
3,070 Added 21.88%
17,101 $1.66 Million
Q4 2020

Feb 08, 2021
SELL
$86.91 - $108.33 $555,354 - $692,228
-6,390 Reduced 31.29%
14,031 $1.34 Million
Q3 2020

Nov 09, 2020
SELL
$96.16 - $135.15 $5.66 Million - $7.95 Million
-58,844 Reduced 74.24%
20,421 $1.97 Million
Q2 2020

Aug 05, 2020
SELL
$85.09 - $130.36 $2.48 Million - $3.8 Million
-29,164 Reduced 26.9%
79,265 $9.67 Million
Q1 2020

May 06, 2020
BUY
$75.11 - $113.76 $2.66 Million - $4.04 Million
35,475 Added 48.63%
108,429 $9.4 Million
Q4 2019

Jan 29, 2020
BUY
$86.8 - $118.57 $139,314 - $190,304
1,605 Added 2.25%
72,954 $7.84 Million
Q3 2019

Nov 01, 2019
SELL
$83.82 - $101.5 $11,567 - $14,007
-138 Reduced 0.19%
71,349 $6.43 Million
Q2 2019

Aug 09, 2019
BUY
$72.24 - $91.27 $50,134 - $63,341
694 Added 0.98%
71,487 $6.04 Million
Q1 2019

May 13, 2019
BUY
$69.31 - $91.53 $75,132 - $99,218
1,084 Added 1.56%
70,793 $6.24 Million
Q4 2018

Feb 11, 2019
SELL
$68.32 - $124.36 $2.52 Million - $4.58 Million
-36,844 Reduced 34.58%
69,709 $4.98 Million
Q3 2018

Oct 26, 2018
SELL
$98.88 - $125.85 $1.29 Million - $1.64 Million
-13,059 Reduced 10.92%
106,553 $13.1 Million
Q2 2018

Aug 08, 2018
BUY
$75.3 - $105.99 $3.54 Million - $4.98 Million
46,978 Added 64.68%
119,612 $11.7 Million
Q1 2018

May 11, 2018
BUY
$75.88 - $92.43 $574,183 - $699,417
7,567 Added 11.63%
72,634 $6.02 Million
Q4 2017

Feb 06, 2018
BUY
$58.53 - $77.59 $2.18 Million - $2.89 Million
37,192 Added 133.42%
65,067 $4.91 Million
Q3 2017

Nov 07, 2017
BUY
$47.97 - $61.28 $1.34 Million - $1.71 Million
27,875
27,875 $1.71 Million

Others Institutions Holding NBIX

# of Institutions
635
Shares Held
93.5M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $14.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email